Financials of Strides Pharma Science Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Strides Pharma Science Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +9869309991,0061,0441,0541,1671,1541,1901,1201,2211,1951,323
Expenses +8717968898768748669839439739029909591,084
Operating Profit115134111129169188184210218218231236240
OPM %12%14%11%13%16%18%16%18%18%19%19%20%18%
Other Income +203-12960-273,299254-120181043
Interest81767970717374525047464342
Depreciation61606049484748484949505153
Profit before tax-70-15770233,36986114106122153245148
Tax %106%3,025%-5%23%55%1%16%21%20%13%14%15%13%
Net Profit +-14-9-14954103,350729086106132208129
EPS in Rs-1.06-0.79-14.545.401.98364.697.819.548.9110.8013.8421.9313.77

Financials of Strides Pharma Science Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +1,1962,8612,7552,8452,1782,7523,3163,0703,6883,8904,5654,859
Expenses +9672,4862,2282,4481,9822,3382,7793,2013,5443,3623,7633,933
Operating Profit229374527398197414537-131145528803925
OPM %19%13%19%14%9%15%16%-4%4%14%18%19%
Other Income +87463291643303-43109-11292-1003,313124
Interest4716818319679156150177261280249179
Depreciation64131126154117174206233243214192202
Profit before tax99213750969030342289-653-268-653,675669
Tax %15%31%12%1%-9%27%11%-27%-21%45%2%14%
Net Profit +8449544668433031258-474-212-943,598575
EPS in Rs141.7812.1544.7174.2536.274.0629.93-51.25-22.44-7.68389.7560.34
Dividend Payout %76%41%10%3%8%345%8%0%-7%-33%1%8%

Financials of Strides Pharma Science Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital608989909090909090929292
Reserves1,0852,5692,6592,3742,5592,4382,6872,2692,1222,0342,4603,015
Borrowings +8923,5423,7002,5203,2212,2352,3483,0253,0302,5171,8801,758
Other Liabilities +4381,2111,5981,6011,9371,3691,8441,5561,3521,1571,4982,062
Total Liabilities2,4757,4108,0466,5857,8076,1316,9696,9406,5945,7995,9296,927
Fixed Assets +7012,6792,9802,9773,6482,0992,2192,3472,3111,8651,8992,387
CWIP171815780620453413447291151162207161
Investments6301,3411,525588702549697540490303409291
Other Assets +9722,5762,7622,4003,0053,0703,6053,7623,6423,4703,4144,088
Total Assets2,4757,4108,0466,5857,8076,1316,9696,9406,5945,7995,9296,927

Financials of Strides Pharma Science Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +837328818760205481-25844701684703
Cash from Investing Activity +50-2,205-1,222570-1451,321-522-119302-150-90-173
Cash from Financing Activity +-4212,944338-1,016194-1,709-16421-214-693-643-453
Net Cash Flow-288812-596-259110-184-5645133-142-4876
Free Cash Flow-157-293-386-212-25658188-326-43672510291
CFO/OP61%40%66%61%59%60%60%199%-30%128%77%84%

Financials of Strides Pharma Science Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1191321321131651241221441291079697
Inventory Days135149209146294254329285257235236305
Days Payable153188221188299259323260220178190244
Cash Conversion Cycle1029212071160119128168165164141157
Working Capital Days-916-122-4-70-70-22-28-11-192438
ROCE %57%8%11%16%2%5%8%-5%-0%7%15%19%